AstraZeneca and COVISHIELD COVID-19 vaccines in Canada: label change
In plain language
This advisory involves the AstraZeneca and COVISHIELD COVID-19 vaccines in Canada. Health Canada is updating the product labels to include capillary leak syndrome as a potential side effect and to update information on blood clots. Talk to your healthcare professional if you have questions or a history of capillary leak syndrome.
What to do
- Talk to your healthcare professional if you have questions about these vaccines.
- If you have a history of capillary leak syndrome, discuss your vaccine options with your healthcare professional.
- Seek immediate medical attention if you experience symptoms of capillary leak syndrome (rapid swelling of arms/legs, sudden weight gain, feeling faint).
- Seek prompt medical attention if you experience symptoms of blood clots with low platelet levels after vaccination.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
This advisory involves the AstraZeneca and COVISHIELD COVID-19 vaccines in Canada. Health Canada is updating the product labels to include capillary leak syndrome as a potential side effect and to update information on blood clots. Talk to your healthcare professional if you have questions or a history of capillary leak syndrome.
What should consumers do?
Talk to your healthcare professional if you have questions about these vaccines. If you have a history of capillary leak syndrome, discuss your vaccine options with your healthcare professional. Seek immediate medical attention if you experience symptoms of capillary leak syndrome (rapid swelling of arms/legs, sudden weight gain, feeling faint). Seek prompt medical attention if you experience symptoms of blood clots with low platelet levels after vaccination.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on June 29, 2021.
Is the AstraZeneca, COVISHIELD brand affected by this recall?
Yes, AstraZeneca, COVISHIELD products are affected by this recall. This advisory involves the AstraZeneca and COVISHIELD COVID-19 vaccines in Canada. Health Canada is updating the product labels to include capillary leak syndrome as a potential side effect and to update information on blood clots. Talk to your healthcare professional if you have questions or a history of capillary leak syndrome.